CancerGeneNet

Not in Signor In Signor

Click on

to show graph legend
Click on any node or edge to view details about them

	level 1	connect
	level 2	first neighbors
	level 3	all
	Include physical interactions (score>0.4)

(note: analysis will be performed for input proteins and up to 50 total proteins, the non-input ones being randomly selected) ℹ

Cancer Modules ▾ ◂

press row to view shared entities
mTOR in cancer	(1/15)
Shared Entities: AKT
FLT3 in AML	(7/40)
Shared Entities: BRAF PTPN11 ERK1/2 JAK2 KRAS AKT MEK1/2
NPM1_new	(6/24)
Shared Entities: BRAF PTPN11 ERK1/2 AKT MEK1/2 NRAS
HaematopoiesisTranscriptionalControl	(1/17)
Shared Entities: HRAS
AML1-ETO in AML	(1/18)
Shared Entities: JAK2
KIT in AML	(7/30)
Shared Entities: BRAF PTPN11 ERK1/2 JAK2 AKT MEK1/2 NRAS
miRNA in AML	(1/35)
Shared Entities: AKT
BCR-ABL in AML	(6/20)
Shared Entities: BRAF ERK1/2 JAK2 KRAS AKT MEK1/2
ASXL1 in AML	(1/13)
Shared Entities: AKT
ErbB receptors in cancer	(5/12)
Shared Entities: BRAF ERK1/2 AKT HRAS MEK1/2
RTKs in cancer	(5/12)
Shared Entities: BRAF ERK1/2 AKT HRAS MEK1/2
WNT/FLT3	(3/27)
Shared Entities: ERK1/2 PRKACA AKT
Triple mutant AML	(2/18)
Shared Entities: ERK1/2 AKT
FLT3-ITD signaling	(7/70)
Shared Entities: BRAF PTPN11 ERK1/2 AKT1 KRAS AKT MEK1/2
AML_TRIPLETS	(6/22)
Shared Entities: BRAF PTPN11 ERK1/2 AKT MEK1/2 NRAS
Onco-fusion proteins in AML	(2/27)
Shared Entities: JAK2 NRAS
FLT3-ITD in AML	(2/37)
Shared Entities: ERK1/2 AKT
all cancer modules	(11/256)